127 related articles for article (PubMed ID: 1649229)
1. On a possible protective effect of HLA-A11 against skin cancer and keratotic skin lesions in renal transplant recipients.
Bouwes Bavinck JN; Kootte AM; Van Der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
J Invest Dermatol; 1991 Aug; 97(2):269-72. PubMed ID: 1649229
[TBL] [Abstract][Full Text] [Related]
2. Relation between HLA antigens and skin cancer in renal transplant recipients in Queensland, Australia.
Bouwes Bavinck JN; Claas FH; Hardie DR; Green A; Vermeer BJ; Hardie IR
J Invest Dermatol; 1997 May; 108(5):708-11. PubMed ID: 9129219
[TBL] [Abstract][Full Text] [Related]
3. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
4. Skin cancers and HLA frequencies in renal transplant recipients.
Czarnecki D; Watkins F; Leahy S; Dyall-Smith D; Levis A; Nicholson I; Tait B
Dermatology; 1992; 185(1):9-11. PubMed ID: 1638083
[TBL] [Abstract][Full Text] [Related]
5. HLA-A11 in renal allograft recipients with skin cancer.
McGregor JM; Reddi G; MacDonald D; Vaughan RW; Welsh KI
J Invest Dermatol; 1992 Feb; 98(2):261-2. PubMed ID: 1571047
[No Abstract] [Full Text] [Related]
6. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
[TBL] [Abstract][Full Text] [Related]
7. HLA-A11-associated resistance to skin cancer in renal-transplant recipients.
Bavinck JN; Kootte AM; van der Woude FJ; Vandenbroucke JP; Vermeer BJ; Claas FH
N Engl J Med; 1990 Nov; 323(19):1350. PubMed ID: 2215624
[No Abstract] [Full Text] [Related]
8. Human leukocyte antigen type as a risk factor for nonmelanomatous skin cancer in patients after renal transplantation.
Bock A; Bliss RL; Matas A; Little JA
Transplantation; 2004 Sep; 78(5):775-8. PubMed ID: 15371688
[TBL] [Abstract][Full Text] [Related]
9. Relation between skin cancer, humoral responses to human papillomaviruses, and HLA class II molecules in renal transplant recipients.
Bavinck JN; Gissmann L; Claas FH; Van der Woude FJ; Persijn GG; Ter Schegget J; Vermeer BJ; Jochmus I; Müller M; Steger G
J Immunol; 1993 Aug; 151(3):1579-86. PubMed ID: 8393047
[TBL] [Abstract][Full Text] [Related]
10. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
11. TP53 polymorphism of exon 4 at codon 72 in cutaneous squamous cell carcinoma and benign epithelial lesions of renal transplant recipients and immunocompetent individuals: lack of correlation with human papillomavirus status.
Cairey-Remonnay S; Humbey O; Mougin C; Algros MP; Mauny F; Kanitakis J; Euvrard S; Laurent R; Aubin F
J Invest Dermatol; 2002 Jun; 118(6):1026-31. PubMed ID: 12060398
[TBL] [Abstract][Full Text] [Related]
12. HLA alleles in renal transplant recipients with nonmelanoma skin cancer in southeastern Brazil.
Rogel CS; Souza-Santana FC; Marcos EVC; Ogawa MM; Basso G; Tomimori J
An Bras Dermatol; 2019 Jul; 94(3):287-292. PubMed ID: 31365656
[TBL] [Abstract][Full Text] [Related]
13. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.
Bavinck JN; Tieben LM; Van der Woude FJ; Tegzess AM; Hermans J; ter Schegget J; Vermeer BJ
J Clin Oncol; 1995 Aug; 13(8):1933-8. PubMed ID: 7636533
[TBL] [Abstract][Full Text] [Related]
14. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
15. T6+ and HLA-DR+ cell numbers in epidermis of immunosuppressed renal transplant recipients.
Kelly G; Scheibner A; Murray E; Sheil R; Tiller D; Horvath J
J Cutan Pathol; 1987 Aug; 14(4):202-6. PubMed ID: 3114340
[TBL] [Abstract][Full Text] [Related]
16. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
17. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients: a comment.
Goldberg LH; Griego RD
Arch Dermatol; 1995 Jan; 131(1):107-8. PubMed ID: 7880308
[No Abstract] [Full Text] [Related]
18. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
19. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer.
de Jong-Tieben LM; Berkhout RJ; ter Schegget J; Vermeer BJ; de Fijter JW; Bruijn JA; Westendorp RG; Bouwes Bavinck JN
Transplantation; 2000 Jan; 69(1):44-9. PubMed ID: 10653378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
